Financials
- Market Capitalization 11.99 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-3 449
Índice preço/fluxo de caixa
5.56
Related tickers
| # | Nome | Preços | 24h % | 7d % | 1M % | 1A % | Capitalização de mercado | Últimos 7 dias | |
|---|---|---|---|---|---|---|---|---|---|
| 809 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 533.76 USD | -1.83% | +3.24% | +5.58% | +26.00% | 12.33 B USD | ||
| 810 | CORT Corcept Therapeutics Incorporated - Common Stock | 113.88 USD | -2.61% | -5.54% | +1.68% | +55.21% | 12.31 B USD | ||
| 827 | HALO Halozyme Therapeutics, Inc. - Common Stock | 105.35 USD | -1.47% | -2.53% | +28.88% | +57.71% | 11.96 B USD | ||
| 852 | TECH Bio-Techne Corp - Common Stock | 72.35 USD | -0.17% | +0.11% | +0.47% | +33.56% | 11.35 B USD |